Table 2.

Summary of median and mean overall survival in AT/RT (BT12) orthotopic xenografts treated with PECE HGs loaded at 30 or 50% (w/w) with combined CHIR and RBV

Treatment following tumour resection	n	Mean survival (days)a	Median survival (days)	SEM	LTS	%LTS
Control	8	36.9	18.0	13.3	0	0
Blank PECE	8	22.8	19.5	3.1	0	0
10 Gy XRT	10	57.3	59.0	10.1	0	0
PECE with (CHIR + RBV) @ 30% (w/w)	10	70.5	56.0	14.5	1	10
PECE with (CHIR + RBV) @ 50% (w/w)	10	54.2	45.5	11.6	1	10

^aEstimation is limited to the longest survival time if censored